GlassScriptPhysician profile
Marc David Cohen
NPI 1083602593
$2,278.94
in general payments reported to CMS, 2019-2025
24 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573 · 2020: $158 · 2021: $47.58 · 2022: $351 · 2023: $644 · 2024: $206 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,146 · Travel and Lodging: $3.46.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,146.16 |
| Travel and Lodging | $3.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $443.43 | 2019-2025 | |
| Rikco International, LLC | $346.00 | 2019 | |
| Urgo Medical North America, LLC | $281.60 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Convatec INC. | $225.22 | 2023 | |
| Smith+Nephew, INC. | $156.59 | 2019-2025 | Grafix, Grafix Pl, Stravix Pl |
| Acera Surgical, INC. | $141.66 | 2023 | Restrata Wound Matrix |
| Abbvie INC. | $139.82 | 2022-2023 | Dalvance |
| Averitas Pharma INC. | $110.88 | 2023-2025 | Qutenza |
| Organogenesis INC. | $96.26 | 2022 | |
| Stryker Corporation | $72.93 | 2023 | Claw II |
| Tactile Systems Technology INC | $33.71 | 2023-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Treace Medical Concepts, INC. | $29.27 | 2022 | |
| Boston Scientific Corporation | $27.42 | 2019-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $27.37 | 2021-2023 | Jublia |
| Dynasplint Systems INC. | $24.00 | 2025 | Dynasplint |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $19.26 | 2019 | |
| Zimvie INC. | $17.07 | 2024 | |
| Paratek Pharmaceuticals, INC. | $14.10 | 2024 | Nuzyra |
| Sebela Pharmaceuticals INC. | $13.69 | 2023 | Naftin |
| Medtronic Vascular, INC. | $13.45 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.10 | 2022 | |
| Zimmer Biomet Holdings, INC. | $11.31 | 2020 | |
| Kerecis Limited | $10.98 | 2022 | |
| Melinta Therapeutics, LLC | $10.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.